Time course of 25(OH)D3vitamin D3 as well as PTH (parathyroid hormone) during fracture healing of patients with normal and low bone mineral density (BMD)

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Wöfl, Christoph ^a   Englert, Sarah ^a   Moghaddam, Arash A ^a   Zimmermann, Gerald ^b   Schmidt Gayk, Gerhard ^c   Höner, Bernd ^d   Hogan, Aidan ^a   Lehnhardt, Marcus ^e   Grützner, Paul A ^a   Kolios, Leila ^e  

^a Trauma Centre Ludwigshafen   (Germany)

^b TKH Mannheim ^*  (Germany)

^c Clinical Laboratory Limbach   (Germany)

^d SRH UNIVERSITY HEIDELBERG   (Germany)

^e Burn Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCIUM; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FEMUR FRACTURE; FRACTURE HEALING; HUMAN; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; RADIUS FRACTURE;

ABSORPTIOMETRY, PHOTON; BIOLOGICAL MARKERS; BONE DENSITY; CALCIFEDIOL; FEMALE; FEMORAL FRACTURES; FRACTURE HEALING; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; RADIUS FRACTURES; SHOULDER FRACTURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872286083     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-6     Document Type: Article

References (36)

1. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study on younger and older adults. Bischoff-Farrari HA, Dietrich T, Orav EJ, Dawson-Hughes B, Am J Med 2004 1 634 639 (Pubitemid 38490539)
2. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P, J Clin Endocrinol Metab 2009 94 1244 1250 10.1210/jc.2008-1832 19158198
3. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, et al. J Int Med 2006 260 245 254 10.1111/j.1365-2796.2006.01685.x (Pubitemid 44253638)
4. Vitamin D, deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Lips P, Endocr Rev 2001 22 477 501 10.1210/er.22.4.477 11493580 (Pubitemid 32762324)
5. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR, Bone 2002 30 771 777 10.1016/S8756-3282(02)00692-0 11996918 (Pubitemid 34468001)
6. Vitamin D deficiency, muscle function, and falls in elderly people. Janssen HC, Samson MM, Verhaar HJ, Am J Clin Nutr 2002 75 611 615 11916748 (Pubitemid 34250675)
7. Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Sambrook PN, Seeman E, Phillips SR, Ebeling PR, The Medical Journal of Australia 2002 176 1 16
8. Party Writing Group. Osteoporosis, Clinical guidelines for Prevention and Treatment. Update on Pharmacological Interventions and an Algorithm for Management London: Royal College of Physicians 2001 1 14
9. Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture. Seo EG, Norman AW, J Bone Miner Res 1997 12 598 606 10.1359/jbmr.1997.12.4.598 9101371 (Pubitemid 27155219)
10. Serum and bone vitamin D metabolites in elective patients and patients after fracture. Alkalay D, Shany S, Dekel S, J Bone Joint Surg Br 1989 71 85 87 2783695 (Pubitemid 19049587)
11. Parathyroid hormone, calcitonin and vitamin D metabolites during normal fracture healing in humans a preliminary report. Meller Y, Kestenbaum RS, Shany S, Galinsky D, Zuili I, et al. Clinical Orthopedics and Related Research 1984 183 238 245 (Pubitemid 14156119)
12. Parathhormone, calcitonin and vitamin D metabolites during normal fracture healing in geriatric patients. Meller Y, Kestenbaum RS, Shany S, Galinsky D, Zuili I, et al. Clinical Orthopedics and Related Research 1985 199 272 274
13. Understanding parathyroid hormone action. Partridge NC, Li X, Qin L, Annals of the New York Acededmy of Science 2006 1068 187 193 10.1196/annals.1346.024 (Pubitemid 43824149)
14. Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. Gagnon C, Li V, Eberling PR, Clin Interv Aging 2008 3 4 635 645 19281056
15. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. Strewler GJ, Stern PH, Jacobs JW, Eveloff L, Klein RF, Leung SC, et al. J Clin Invest 1987 80 1803 1807 10.1172/JCI113275 3680530 (Pubitemid 18007159)
16. Bone resorption by osteoclasts. Teitelbaum SL, Science 2000 289 1504 1508 10.1126/science.289.5484.1504 10968780
17. Exogenous PTH and endogenous 1,25-dihydroxyvitamin D Are complementary in inducing an anabolic effect on bone. Samadfam R, Xia Q, Miao D, Hendy GN, Goltzman D, J Bone Miner Res 2008 23 1257 1266 10.1359/jbmr.080318 18348699 (Pubitemid 352040180)
18. Parathyroid hormone stimulates the bone apposition rate independently of ist resorptive action: differential effects of intermittent and continuous administration. Tam CS, Heersche JN, Murray TM, Parsons JA, Endocrinology 1982 110 506 512 10.1210/endo-110-2-506 7056211 (Pubitemid 12162946)
19. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Goltzman D, Arch Biochem Biophys 2008 473 218 224 10.1016/j.abb.2008.03.003 18358824
20. A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis. Sone T, Fukunaga M, Ono S, Nishiyama T, Miner Electrolyte Metab 1995 21 232 235 7565456
21. Parathyroid hormone and teriparatide fort he treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Hodsman AB, Bauer DC, Dempster D, Dian L, Hanley DA, Harris ST, et al. Endocr Rev 2005 26 688 703 10.1210/er.2004-0006 15769903 (Pubitemid 41127277)
22. Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Komrakova M, Stuermer EK, Werner C, Wicke M, Kolios L, Sehmisch S, et al. Bone 2010 47 480 492 10.1016/j.bone.2010.05.013 20580683
23. Vitamin D metabolism, cartilage and bone fracture repair. St-Arnaud R, Naja RP, Mol Cel Endocr 2011 347 48 54 10.1016/j.mce.2011.05.018
24. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, et al. J Bone Miner Res 1998 13 325 349 10.1359/jbmr.1998.13.3. 325 9525333 (Pubitemid 28146215)
25. Minireview: vitamin D receptor: new assignments for an already busy receptor. Norman AW, Endocrinology 2006 147 5542 5548 10.1210/en.2006-0946 16946007 (Pubitemid 44833469)
26. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G, Osteoporos Int 2011 published online 08 June 10.1007/s00198-011-1659-1
27. Evidence for a 24R, 25(OH)2-vitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus. Seo EG, Kato A, Norman AW, Biochem Biophys Res Commun 1196 225 203 208
28. Studies on 24R, 25-dihydroxyvitamin D3: evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus. Kato A, Seo EG, Einhorn TA, Bishop JE, Norman AW, Bone 1998 23 141 146 10.1016/S8756-3282(98) 00085-4 9701473 (Pubitemid 28379875)
29. Influence of vitamin D levels on bone mineral density and osteoporosis. Sadat-Ali M, Al Elq AH, Al-Turki HA, AL-Mulhim FA, Al-Ali AK, Ann Saudi Med 2011 31 602 608 10.4103/0256-4947.87097 22048506
30. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. GArnero P, Munoz F, Sornay-Rendu E, Delmas PD, Bone 2007 40 716 722 10.1016/j.bone.2006.09.026 17112798 (Pubitemid 46201944)
31. Association between vitamin D and bone mineral density in Iranian postmenopausal women. Hosseinpanah F, Rambod M, Hossein-nejad A, Larijani B, Azizi F, J Bone Miner Metab 2008 26 86 92 10.1007/s00774-007-0791-7 18095069 (Pubitemid 350308004)
32. Effects of vitamin D insufficiency on bone mineral density in African American men. Akhter N, Sinnott B, Mahmood K, Rao S, Kukreja S, Barengolts E, Osteoporos Int 2009 20 745 750 10.1007/s00198-008-0746-4 18820989
33. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Swarthout JT, D'Alonzo RC, Selvamuruga N, Partridge NC, Gene 2002 282 1 17 10.1016/S0378-1119(01)00798-3 11814673 (Pubitemid 34117557)
34. Espression cloning of s common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells; a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, et al. Proc Natl Acad Sci USA 1992 89 2732 2736 10.1073/pnas.89.7.2732 1313566
35. Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism. Habener JF, Rosenblatt M, Potts JT Jr, Physiol Rev 1984 64 985 1053 6330779 (Pubitemid 14084549)
36. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). Mosekilde L, Sogaard CH, Danielsen CC, Torring O, Endocrinology 1991 129 421 428 10.1210/endo-129-1-421 2055197